Bangwei Wu

1.2k total citations
39 papers, 941 citations indexed

About

Bangwei Wu is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Bangwei Wu has authored 39 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 15 papers in Cardiology and Cardiovascular Medicine and 10 papers in Epidemiology. Recurrent topics in Bangwei Wu's work include Atherosclerosis and Cardiovascular Diseases (12 papers), T-cell and B-cell Immunology (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Bangwei Wu is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (12 papers), T-cell and B-cell Immunology (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Bangwei Wu collaborates with scholars based in China, United States and Hong Kong. Bangwei Wu's co-authors include Qiutang Zeng, Kai Meng, Kunwu Yu, Qingwei Ji, Yujie Zhou, Yucheng Zhong, Yingzhong Lin, Xiaoqi Zhao, Xiaobo Mao and Xinping Luo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Bangwei Wu

39 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bangwei Wu China 18 401 385 228 154 145 39 941
Salma Kotti France 10 265 0.7× 359 0.9× 340 1.5× 143 0.9× 42 0.3× 25 965
Tarun Tyagi India 13 351 0.9× 153 0.4× 146 0.6× 131 0.9× 123 0.8× 23 1.1k
Ovidiu Simion Cotoi Romania 11 271 0.7× 209 0.5× 96 0.4× 110 0.7× 62 0.4× 67 643
Eric Tu United States 12 279 0.7× 549 1.4× 89 0.4× 92 0.6× 81 0.6× 21 1.1k
Joon Ho Lee South Korea 19 371 0.9× 173 0.4× 51 0.2× 173 1.1× 149 1.0× 45 999
Heiko Methe Germany 16 306 0.8× 471 1.2× 127 0.6× 162 1.1× 102 0.7× 34 969
Adriana Delwail France 16 365 0.9× 645 1.7× 152 0.7× 110 0.7× 36 0.2× 24 1.2k
Martin Mollenhauer Germany 17 321 0.8× 294 0.8× 146 0.6× 114 0.7× 283 2.0× 43 997
Wenfeng Tan China 25 508 1.3× 385 1.0× 49 0.2× 226 1.5× 187 1.3× 73 1.4k
Elba Reyes‐Maldonado Mexico 17 232 0.6× 278 0.7× 48 0.2× 105 0.7× 72 0.5× 75 976

Countries citing papers authored by Bangwei Wu

Since Specialization
Citations

This map shows the geographic impact of Bangwei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bangwei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bangwei Wu more than expected).

Fields of papers citing papers by Bangwei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bangwei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bangwei Wu. The network helps show where Bangwei Wu may publish in the future.

Co-authorship network of co-authors of Bangwei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Bangwei Wu. A scholar is included among the top collaborators of Bangwei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bangwei Wu. Bangwei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Qingyu, Jian Li, Yiming Wang, et al.. (2024). Cardiac fibroblast-specific expression of IL-37 confers the protective effects on fibrosis in diabetic cardiomyopathy mice by regulating SOCS3-STAT3 axis. Journal of Geriatric Cardiology. 21(11). 1060–1070. 1 indexed citations
2.
Wang, Yiming, Jinjin Zhang, Bangwei Wu, et al.. (2022). IL-37 improves mice myocardial infarction via inhibiting YAP-NLRP3 signaling mediated macrophage programming. European Journal of Pharmacology. 934. 175293–175293. 15 indexed citations
3.
Zhong, Haoxuan, Wei Zhang, Liping Han, et al.. (2021). NOD2-mediated P2Y12 upregulation increases platelet activation and thrombosis in sepsis. Biochemical Pharmacology. 194. 114822–114822. 15 indexed citations
4.
Xie, Kun, Bangwei Wu, Zhiyong Qi, et al.. (2020). A stricter control of low-density lipoprotein is necessary for thrombosis reduction in “lower thrombosis risk” patients with atrial fibrillation: a multicenter retrospective cohort study. Journal of Thrombosis and Thrombolysis. 50(4). 849–857. 4 indexed citations
5.
Zhou, Peng, Yikai Zhao, Bangwei Wu, et al.. (2020). Increased serum interleukin-6 level as a predictive biomarker for atrial fibrillation: A systematic review and meta-analysis. Revista Portuguesa de Cardiologia. 39(12). 723–728. 18 indexed citations
6.
Cheng, Min, Junjie Yang, Xiaoqi Zhao, et al.. (2019). Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells. Nature Communications. 10(1). 959–959. 170 indexed citations
7.
Shen, Jun, et al.. (2019). Factors influencing cognitive function in patients with atrial fibrillation: a cross-sectional clinical study. Journal of International Medical Research. 47(12). 6041–6052. 4 indexed citations
8.
Wu, Bangwei, Jian Li, Xinyu Zhuang, et al.. (2018). TLR4 Activation Promotes the Progression of Experimental Autoimmune Myocarditis to Dilated Cardiomyopathy by Inducing Mitochondrial Dynamic Imbalance. Oxidative Medicine and Cellular Longevity. 2018(1). 3181278–3181278. 39 indexed citations
9.
Ji, Qingwei, Kai Meng, Kunwu Yu, et al.. (2017). Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice. Scientific Reports. 7(1). 3310–3310. 50 indexed citations
10.
Zhuang, Xinyu, Bangwei Wu, Jian Li, et al.. (2017). The emerging role of interleukin‐37 in cardiovascular diseases. Immunity Inflammation and Disease. 5(3). 373–379. 22 indexed citations
11.
Meng, Kai, Qiutang Zeng, Qinghua Lu, et al.. (2015). Valsartan Attenuates Atherosclerosis via Upregulating the Th2 Immune Response in Prolonged Angiotensin II-Treated ApoE−/− Mice. Molecular Medicine. 21(1). 143–153. 27 indexed citations
12.
13.
Liu, Yuzhou, Xiaoqi Zhao, Yucheng Zhong, et al.. (2015). Heme Oxygenase-1 Restores Impaired GARP+CD4+CD25+ Regulatory T Cells from Patients with Acute Coronary Syndrome by Upregulating LAP and GARP Expression on Activated T Lymphocytes. Cellular Physiology and Biochemistry. 35(2). 553–570. 11 indexed citations
14.
Chang, Chao, Qingwei Ji, Bangwei Wu, et al.. (2015). Chemerin15‐Ameliorated Cardiac Ischemia‐Reperfusion Injury Is Associated with the Induction of Alternatively Activated Macrophages. Mediators of Inflammation. 2015(1). 563951–563951. 26 indexed citations
15.
Zhao, Xiaoqi, Yuzhou Liu, Bo Liu, et al.. (2015). Atorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP. Mediators of Inflammation. 2015(1). 841472–841472. 11 indexed citations
16.
Meng, Kai, Yucheng Zhong, Xiaobo Mao, et al.. (2014). Impairment of Circulating CD4+CD25+GARP+Regulatory T Cells in Patients with Acute Coronary Syndrome. Cellular Physiology and Biochemistry. 33(3). 621–632. 18 indexed citations
17.
18.
Zhu, Zhengfeng, Kai Meng, Yucheng Zhong, et al.. (2014). Impaired Circulating CD4+LAP+ Regulatory T Cells in Patients with Acute Coronary Syndrome and Its Mechanistic Study. PLoS ONE. 9(2). e88775–e88775. 20 indexed citations
19.
Wu, Bangwei, Kai Meng, Qingwei Ji, et al.. (2014). Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice. Clinical & Experimental Immunology. 176(3). 438–451. 100 indexed citations
20.
Wu, Bangwei, Qiutang Zeng, Kai Meng, & Qingwei Ji. (2013). The potential role of IL-37 in atherosclerosis.. PubMed. 68(11). 857–60. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salma Kotti Breakdown of academic impact, for papers by Tarun Tyagi Breakdown of academic impact, for papers by Ovidiu Simion Cotoi Breakdown of academic impact, for papers by Eric Tu Breakdown of academic impact, for papers by Joon Ho Lee Breakdown of academic impact, for papers by Heiko Methe Breakdown of academic impact, for papers by Adriana Delwail Breakdown of academic impact, for papers by Martin Mollenhauer Breakdown of academic impact, for papers by Wenfeng Tan Breakdown of academic impact, for papers by Elba Reyes‐Maldonado
Rankless by CCL
2026